Clinical trial · Observational
Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study
NCT03197259CI-TRIAL-00050543CLLTRegistryunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemia | ONTOLOGY_EXACT | 0.98 |
| Del(17P) | Double-Expressor Lymphoma | ALIAS | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- First line therapy therapy protocol distrubition
- timeFrame
- 36 months
- description
- The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed as CLL * 18 years or older * Able and willing to provide the written informed consent Exclusion Criteria: * Younger than 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.